Study shows terlipressin improves kidney function in hepatorenal syndrome

Newly published research from the United Kingdom demonstrates terlipressin is effective for improving kidney function in hospitalized patients with hepatorenal syndrome type 1.“Acute kidney injury (AKI) is a complication of advanced liver disease, occurring in approximately 3.23% of hospitalized adult patients with chronic liver disease including cirrhosis,” Kevin Moore, MD, of the UCL Institute of Liver and Digestive Health at the Royal Free Hospital, University College London, and colleagues wrote. “Hepatorenal syndrome (HRS) is a type of functional AKI that results fromRead More

Share on facebook
Share on twitter
Share on linkedin